3 completed, 1 terminated, 1 withdrawn. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Blaze Bioscience Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery Near Infrared Imaging, Therapeutic Conventional Surgery, Tozuleristide - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8 | Phase 1 / Phase 2 | Terminated | University of Washington | 8 | 2024-04-17 | 2026-09-16 |
| Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery BLZ-100 - Sarcoma, Soft Tissue | Phase 1 | Withdrawn | Blaze Bioscience Inc. | 2015-09-01 | 2016-05-26 | |
| Exploratory Study of Safety and ex Vivo Fluorescence of BLZ-100 in Adult Subjects With Solid Tumors Undergoing Surgery BLZ-100 - Tumors, Breast | Phase 1 | Completed | Blaze Bioscience Inc. | 30 | 2015-07-01 | 2017-07-13 |
| Study of BLZ-100 in Pediatric Subjects With CNS Tumors BLZ-100 - Central Nervous System Tumors | Phase 1 | Completed | Blaze Bioscience Inc. | 29 | 2015-06-01 | 2023-02-21 |
| Safety Study of BLZ-100 in Adult Subjects With Glioma Undergoing Surgery BLZ-100 - Glioma | Phase 1 | Completed | Blaze Bioscience Inc. | 17 | 2014-10-01 | 2016-04-06 |
Brain Neoplasms (1) · Breast Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Mouth Neoplasms (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
tozuleristide (5)
United States (5) · Australia (1)
Charles Forscher, MD (1) · Chirag Patil (1) · Emily Marchiano (1) · Kristi M Harrington, MD (1) · Sarah Leary, MD, MS (1)
261201400046C-0-0-1 (1)